Optimal indication of neoadjuvant chemoradiotherapy for pancreatic cancer
Crossref DOI link: https://doi.org/10.1007/s00423-015-1304-0
Published Online: 2015-05-01
Published Print: 2015-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sho, Masayuki
Akahori, Takahiro
Tanaka, Toshihiro
Kinoshita, Shoichi
Nagai, Minako
Nishiwada, Satoshi
Tamamoto, Tetsuro
Nishiofuku, Hideyuki
Ohbayashi, Chiho
Hasegawa, Masatoshi
Kichikawa, Kimihiko
Nakajima, Yoshiyuki
Text and Data Mining valid from 2015-05-01